Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideaki Shimada

Showing results (191-200 of 365) with videos related to

Pageof 37
Sort By:
Alcoholism, Clinical and Experimental Research|August 29, 2002
Tandem repeat polymorphism of the CYP2E1 gene: an association study with esophageal cancer and lung cancerSakae Itoga, Fumio Nomura, Yasuhiko Makino, et al.
American Journal of Cancer Research|February 14, 2019
A p53-stabilizing agent, CP-31398, induces p21 expression with increased G2/M phase through the YY1 transcription factor in esophageal carcinoma defective of the p53 pathwayBoya Zhong, Masato Shingyoji, Michiko Hanazono, et al.
Springerplus|July 21, 2015
A clinical protocol to inhibit the HGF/c-Met pathway for malignant mesothelioma with an intrapleural injection of adenoviruses expressing the NK4 geneYuji Tada, Kenzo Hiroshima, Hideaki Shimada, et al.
Hepato-Gastroenterology|June 22, 2005
Generation of antitumor immunity against large colon tumors by repeated runs of electrochemotherapyYoshio Gunji, Masaya Uesato, Shinichi Miyazaki, et al.
Cell Death & Disease|July 7, 2021
An MDM2 inhibitor achieves synergistic cytotoxic effects with adenoviruses lacking E1B55kDa gene on mesothelioma with the wild-type p53 through augmenting NFI expressionThao Thi Thanh Nguyen, Masato Shingyoji, Michiko Hanazono, et al.
Surgery Today|May 17, 2017
Serum p53 antibody as a potential tumor marker in extrahepatic cholangiocarcinomaRei Okada, Hideaki Shimada, Yuichiro Otsuka, et al.
BMC Cancer|September 27, 2014
Mesenchymal stem cells are efficiently transduced with adenoviruses bearing type 35-derived fibers and the transduced cells with the IL-28A gene produces cytotoxicity to lung carcinoma cells co-culturedTakeo Suzuki, Kiyoko Kawamura, Quanhai Li, et al.
Clinical Journal of Gastroenterology|March 3, 2018
Five-year postsurgical monitoring of serum p53 antibody for locally advanced esophageal squamous cell carcinomaRyosuke Kochi, Satoshi Yajima, Tatsuki Nanami, et al.
International Journal of Oncology|February 13, 2009
Decrease in chemosensitivity against anticancer drugs by an esophageal squamous cell carcinoma SEREX antigen, AISECTakaki Hiwasa, Hideaki Shimada, Mari Kuboshima, et al.
World Journal of Surgery|March 9, 2007
Surgical outcome of elderly patients 75 years of age and older with thoracic esophageal carcinomaHideaki Shimada, Tooru Shiratori, Shinnichi Okazumi, et al.
Pageof 37

Showing results (191-200 of 365) with videos related to

Sort By:
Pageof 37
Alcoholism, Clinical and Experimental Research|August 29, 2002
Tandem repeat polymorphism of the CYP2E1 gene: an association study with esophageal cancer and lung cancerSakae Itoga, Fumio Nomura, Yasuhiko Makino, et al.
American Journal of Cancer Research|February 14, 2019
A p53-stabilizing agent, CP-31398, induces p21 expression with increased G2/M phase through the YY1 transcription factor in esophageal carcinoma defective of the p53 pathwayBoya Zhong, Masato Shingyoji, Michiko Hanazono, et al.
Springerplus|July 21, 2015
A clinical protocol to inhibit the HGF/c-Met pathway for malignant mesothelioma with an intrapleural injection of adenoviruses expressing the NK4 geneYuji Tada, Kenzo Hiroshima, Hideaki Shimada, et al.
Hepato-Gastroenterology|June 22, 2005
Generation of antitumor immunity against large colon tumors by repeated runs of electrochemotherapyYoshio Gunji, Masaya Uesato, Shinichi Miyazaki, et al.
Cell Death & Disease|July 7, 2021
An MDM2 inhibitor achieves synergistic cytotoxic effects with adenoviruses lacking E1B55kDa gene on mesothelioma with the wild-type p53 through augmenting NFI expressionThao Thi Thanh Nguyen, Masato Shingyoji, Michiko Hanazono, et al.
Surgery Today|May 17, 2017
Serum p53 antibody as a potential tumor marker in extrahepatic cholangiocarcinomaRei Okada, Hideaki Shimada, Yuichiro Otsuka, et al.
BMC Cancer|September 27, 2014
Mesenchymal stem cells are efficiently transduced with adenoviruses bearing type 35-derived fibers and the transduced cells with the IL-28A gene produces cytotoxicity to lung carcinoma cells co-culturedTakeo Suzuki, Kiyoko Kawamura, Quanhai Li, et al.
Clinical Journal of Gastroenterology|March 3, 2018
Five-year postsurgical monitoring of serum p53 antibody for locally advanced esophageal squamous cell carcinomaRyosuke Kochi, Satoshi Yajima, Tatsuki Nanami, et al.
International Journal of Oncology|February 13, 2009
Decrease in chemosensitivity against anticancer drugs by an esophageal squamous cell carcinoma SEREX antigen, AISECTakaki Hiwasa, Hideaki Shimada, Mari Kuboshima, et al.
World Journal of Surgery|March 9, 2007
Surgical outcome of elderly patients 75 years of age and older with thoracic esophageal carcinomaHideaki Shimada, Tooru Shiratori, Shinnichi Okazumi, et al.
Pageof 37